2016 Speakers

Hal is President of Healthcare at Digital Reasoning, following its acquisition of Shareable, where he was President and CEO. A successful entrepreneur, investor, and health care business leader, he was VP and General Manager of Hospital Solutions for Availity, LLC, and Chairman, President and CEO of RevPoint Healthcare Technologies, Inc. Other notable roles include CEO of Data Advantage and leadership roles at Martin Ventures, Cogent Healthcare, Essent Healthcare, InPhact and Arcon Healthcare. He was an attorney at Waller Lansden Dortch and Davis, has two undergraduate degrees from Southern Methodist University, and a law degree from The University of Tennessee.

Sampriti Bhattacharyya is a roboticist, and founder of an underwater drone startup, Hydroswarm. She is a PhD Candidate in Mechanical Engineering at MIT, with a MS in Aerospace Engineering, and a BS in Electrical Engineering. Hydroswarm has gained both national and international attention, being featured by leading outlets like Forbes, The Guardian, Smithsonian, Techcrunch and many others. Sampriti has been as named one of Forbes 30 under 30, Class of 2016; Robohub’s 25 Women in Robotics, 2014; and Connected World’s 2016 Women of M2M. She is an active advocate for women in STEM fields.

Dr. Greg Carroll, MD is the Northwest Market President and Corporate Clinical Leader for GoHealth Urgent Care, one of the nation’s fastest growing urgent care companies.  GoHealth Urgent Care partners with leading health systems, such as Legacy Health in Portland, Northwell Health (f/k/a North Shore-LIJ) in New York, and Dignity Health in Northern California, to develop, manage and lead urgent care centers that deliver an innovative and effortless patient experience that is seamlessly integrated into the community continuum of care. Dr. Carroll leads GoHealth Urgent Care’s partner clinical integration and quality efforts. He has spoken nationally on urgent care clinical integration and the transition from volume to value based care. Prior to joining GoHealth Urgent Care, Dr. Carroll was a managing partner for Emergency Specialists of Oregon. Under Dr. Carroll’s leadership, Emergency Specialists of Oregon launched a successful telemedicine program that provided center of excellence quality of care for community-based hospital populations. Dr. Carroll is also founder and former executive director of Reflex Clinic, an innovative clinic specializing in non-surgical orthopedic care. Dr. Carroll has developed robust education, QI and training programs for advanced practice providers in both emergency medicine and urgent care. Dr. Carroll is board-certified in emergency medicine with over 15 years of experience in clinical care. He trained in the UCLA Health System network, where he remained a clinical instructor after residency. Dr. Carroll received his MD from the Tulane University School of Medicine. He has published research articles in microbiology and physiology.

Michael Doherty is currently working 50% for Roche/Genentech and 50% for Foundation Medicine in 2 related and synergistic roles. He leads the strategic innovation team in Roche Pharma Development, which is focused on the transformation of the drug development process to ensure the future sustainability of drug development. In addition, he is working as an executive adviser to Foundation Medicine to build a capability to sustain the product portfolio through the transformation from CLIAregulation to an FDA oversight. He started his career in 1986 in Regulatory Affairs in the Cyanamid Company (Lederle), based in the UK, working primarily in the field of antibiotics registration with the UK Health Authority. He then joined Sandoz, where he led the Regulatory Group in the UK, undertaking the first European filings under the mutual recognition and centralised procedures with the European Commission. In 1992, Michael joined Rhone Poulenc Rorer (RPR) based in Paris, and took on Global Regulatory responsibility for the respiratory and endocrinology portfolios. He later joined Astra (to become AstraZeneca), where he was first the Head of the Respiratory and Inflammation Regulatory Team and then became Global Head of Drug Development Regulatory Affairs. In 2002, he joined F. Hoffman-La Roche Ltd as Global Head, Regulatory Affairs based in Basel, Switzerland. In 2009, he relocated to Genentech, San Francisco to oversee the integration of the 2 regulatory functions following the full acquisition of Genentech by Roche, and continued in the role of global head of regulatory affairs until the end of 2015. Prior to working in the pharmaceutical industry, Michael worked at the University of Manchester, UK, and Christie Hospital in the Regional Endocrinology Laboratory. He has a BSc in Biochemistry and a fellowship of the Institute of Medical Sciences, UK, and a Diploma in Management Studies from the University of Portsmouth, UK.

Dr. Dugas has been Director of Health and Research at Vitality since 2011. Prior to Vitality, he spent four years teaching in the Department of Kinesiology and Nutrition at the University of Illinois at Chicago. At Vitality, Jonathan’s focus is to ensure the program remains evidence-based and retains its strong scientific foundations. He interacts with multiple academic partners and engages in research activities and the peer-review process with the aim of better understanding how workplace health promotion programs can improve employee health.

Dr. Edward Ewen is Director of Clinical Data and Analytics for Christiana Care Health System. He is responsible for leading his organization’s enterprise information management program and is responsible for coordinating and setting strategy for its data warehousing, data governance, and business analytics activities. He has over 20 years’ experience in health care data warehousing and analytics. He is also a general internist who maintains an active clinical practice in both primary care and hospitalist medicine. Prior to this Dr. Ewen led Christiana Care’s clinical informatics and disease management programs.

Naomi Fried is an innovation and digital health thought leader with more than 15 years of experience.  She was the first VP of Innovation, Medical Information and External Partnerships at Biogen Idec. Previously, she was the first Chief Innovation Officer at Boston Children’s Hospital, where she built and led a team to promote technological and clinical process innovation. Prior to that, she was VP of Innovation and Advanced Technology at Kaiser Permanente where she led an effort to identify and assess new and emerging health care technology. Naomi is on the board of Directors for the American Telemedicine Association.  Naomi received her Ph.D. in Materials Science from MIT and her B.S. in Chemistry from the University of California, Berkeley.

Tamar Goldblatt is the Senior Manager for Population Health Client Solutions at athenahealth. Tamar builds relationships with athena’s Population Health clients, partnering to develop population management strategies and optimizing client performance and guiding high-level strategy. Prior to athenahealth, Tamar was with Blue Cross Blue Shield of Massachusetts, where she negotiated the value-based financial relationship between Blue Cross and executives of integrated health systems and provider organizations. Additionally, she led the development of Blue Cross’ Medicare Advantage risk contracting strategy. Tamar has also served as a consultant with Booz Allen, as well as in state government and earlier in financial services. Ms. Goldblatt holds a Master of Public Policy from Georgetown University and a BA in Health Policy and Political Economy from New York University.

Prior to founding Quartet in 2014, Arun served as a General Partner at Accretive, the firm that launched several successful companies including Accolade. He has also held roles at Palantir Technologies, McKinsey & Company, and The World Bank. Arun received a Masters from the Harvard Kennedy School, where he was a Reynolds Fellow for Social Entrepreneurship, and an undergraduate degree from Duke University. A purpose-driven entrepreneur focused on fixing the U.S. healthcare system, Arun has also worked extensively on development efforts in India, including launching a social enterprise to improve value capture to farmers and creating a quality improvement program for the public healthcare delivery system within the Government of India.

Dennis Hancock leads the Global Commercial Solutions organization for Pfizer and has responsibility for strategy and delivery across three centers of excellence: Mobile and Emerging Technologies, Digital Marketing, and Sales Force Enablement.

Mr. Hancock and the teams he has led have received a number of recent awards: including the #10 spot on InformationWeek’s Elite 100, a CIO 100 award for Innovation, and consistent accolades for execution in the areas of Digital ,Mobile, and Embracing SaaS and Cloud solutions at an enterprise level resulting in repetitive annual savings to Pfizer of > $50MM.

Craig Hankins is vice president of consumer engagement products at UnitedHealthcare. In this role, Mr. Hankins oversees the strategy and delivery of mobile solutions that help consumers more easily navigate the health system and improve their well-being. His responsibilities include developing innovative mobile technologies that serve an array of health care stakeholders, including consumers, health care providers, and employers. He brings to his current role more than 15 years of experience in management and business consulting. He holds an MBA from New York University’s Stern School of Business and a Bachelor of Arts degree from St. Olaf College in Minnesota.

Daniel J. Hilferty is president and chief executive officer of Independence Blue Cross, one of the nation’s leading health insurers.  Mr. Hilferty’s vision is to lead the transformation of health care in America, seeking innovative technologies and new models of care that will increase the quality and lower the cost of care. He led the creation of the Independence Blue Cross Center for Health Care Innovation and launched Tandigm Health, a unique joint venture that arms primary care physicians with the tools and data needed to better manage chronic conditions and deliver more personalized care. He has built business collaborations with world-renowned institutions such as the University of Pennsylvania to conduct cutting-edge research and partnered with Blue Cross and Blue Shield plans and other leaders in health care to purchase dynamic health care companies, including AmeriHealth Caritas, one of the country’s largest Medicaid managed care companies, and NaviNet, which manages the nation’s largest interactive health care network.

Mr. Hilferty serves as chairman of the board of directors for the Blue Cross and Blue Shield Association. He serves on the executive committee of the board of directors of America’s Health Insurance Plans and on the board of Tandigm Health. He also serves on the board of BCS Financial, an innovation partner for Blue companies.

Mr. Hilferty earned his undergraduate degree from St. Joseph’s University, and then served in the Jesuit Volunteer Corps running a community center in Portland, OR. He earned a Master of Public Administration degree from American University.

Todd Hobbs, M.D., is the chief medical officer for North America at Novo Nordisk, where he leads the organization’s focus on the implications of diabetes for the patient, healthcare system and healthcare professionals in the United States and Canada. Dr. Hobbs provides overall medical guidance to Novo Nordisk’s diabetes- and obesity-related projects. He is involved with the optimization of relationships with top key opinion leaders and medical societies, and provides guidance to and participates in consultant advisory boards and key patient and professional associations and top thought leaders in diabetes.

Dr. Hobbs has a unique perspective on and personal dedication to the treatment of diabetes: his own experience with the disease began more than 25 years ago when he was diagnosed with type 1 diabetes. His passion for defeating the disease intensified even more with the diagnosis of one of his sons with the same condition at the age of five.

Dr. Anil Jain is Senior VP, Chief Medical Officer and co-Founder of Explorys, a cloud-based healthcare analytics platform company, acquired in 2015 along with Phytel to form IBM Watson Health. Prior to joining the Explorys Watson Health leadership team, Dr. Jain spent 16 years at the Clinic, most recently as Senior Executive Director of IT where he led several Health IT innovations, including programs to support research and quality informatics for population health and created interactive dashboards to monitor the meaningful use of the Electronic Health Record. He continues to practice and teach Internal Medicine at the Cleveland Clinic.

Dr. Jain serves on a number of advisory boards, has authored more than a 100 publications and abstracts and has given numerous talks at national meetings on the benefits of Health IT. He is a Diplomate of the American Board of Internal Medicine and a Fellow of the American College of Physicians.

Bruce Japsen writes about healthcare for Forbes and is the author of “Inside Obamacare: the Fix for America’s Ailing Health Care System.” He is a regular analyst on Fox News Channel’s “Forbes on Fox,” Chicago’s WBBM Newsradio and WTTW’s ChicagoTonight public affairs program. His work also has appeared in the New York Times, The Motley Fool and Chicago Medicine. He teaches for the University of Iowa School of Journalism’s as an instructor in the Master’s In Strategic Communication program

Dr. Todd Johnson founded Noble.MD in 2012, building on 20 years in entrepreneurial successes combining life science, healthcare research and information technology. Most recently, Todd was VP of Global Marketing for Abbott Labs where he used interactive media to successfully grow the product pipeline and enable Abbott’s spin-out of AbbVie into a publicly traded company. Prior to Abbott, Todd revolutionized proof of concept clinical research at MDS and McKinsey & Company. Todd received his ABA from Oxford, BA and MD from the University of Pennsylvania, and his MBA from the Wharton School of business.

Joseph Kim is a Senior Advisor in Clinical Innovation at Lilly, focusing on developing and implementing innovative patient engagement solutions. He has spent over 17 years in the Pharma industry and has a well known history of innovation, recognized as one of “20 Innovators Changing the Face of the Clinical Trials Industry” by CenterWatch. He holds a BS in Molecular Biology from Lehigh University and an MBA from Villanova. @jopekim

John brings more than 25 years of Healthcare experience to Geisinger Health System. He is responsible for Geisinger’s infrastructure as well as all Mergers/Acquisitions which involve the implementation of systems to meet Geisinger standards. In addition John is responsible for the regional health information exchange, KeyHIE, which currently connects more than 50 organizations throughout Pennsylvania. He also leads the I.T. support to Geisinger’s Tele-Health Programs which consist of e-ICU, Tele-Stroke, Tele-Trauma, Tele-Psych, Tele-Pulmonary, Tele-Echo.

Prior to joining Geisinger, John was VP/CIO for Good Shepherd Rehab Network located in Allentown, Pa. While at Good Shepherd he had the technology responsibility for Good Shepherd Penn Partners, a post-acute hospital and ambulatory clinic network through a joint venture with the University of Pennsylvania Health System located in downtown Philadelphia.

He is a member of the College of Health Information Management Executives (CHIME), Health Information Management System Society (HIMSS), and American Telemedicine Association (ATA), as well as serving on the Central Pennsylvania HIMSS Chapter Board, and the KINBER Board.

David J. Kroll, Ph.D. is a pharmacologist and, since 2012, a contributor to the Pharma & Healthcare page at Forbes.com.

During his 20-year academic career investigating cancer drugs from nature, he was a tenured faculty member at the University of Colorado School of Pharmacy and North Carolina Central University, and senior research pharmacologist at RTI International. Dr. Kroll received 11 teaching awards while at Colorado and considers his freelance writing career an extension of his public and professional educational mission.

Dr. Kroll holds a B.S. in toxicology at the Philadelphia College of Pharmacy and Science and a Ph.D. in pharmacology and therapeutics from the University of Florida. Residing in Durham, North Carolina, he is also an adjunct associate professor of medicine at Duke University.

Nishan Kulatilaka joined Merck in 2014 as an Associate Director in Applied Technology. Operating within Merck IT, the Applied Technology group builds disruptive services and architectures for a rapidly evolving health data landscape.

Nishan leads initiatives to prototype and pilot emerging technologies to determine their efficacy when they intersect with healthcare. Currently, his main area of focus is in the space of blockchain technology and cryptocurrency, with additional work exploring quantum computing and health data standards.

Prior to joining Merck, Nishan was a Technical Coordinator at Epic Systems where he developed and implemented electronic medical record software. Nishan received his BS in Mechanical Engineering from Carnegie Mellon University.

Heather Lavoie serves as Chief Strategy Officer for Geneia, a company helping healthcare organizations improve outcomes and costs through it advanced analytics and insights platform, remote patient monitoring solution, and education and research institute.

During her nearly 30-year tenure in healthcare, Heather has led start-ups, health plans and provider organizations, as well as initiatives to identify and replicate best practices in healthcare use and delivery. She has directed projects for private and public organizations on transparency, diversification, product development and delivery, health cost escalation, operations consolidation, data warehousing, data analytics, and financial reporting.

Heather is a graduate of Notre Dame College and received a Masters of Business Administration from Southern New Hampshire University. She is a sought-after national speaker on healthcare issues.

Mr. Makowka has over fifteen years’ experience in strategic consulting and market research. For more than half of that time, he has been focused on the wants and needs of the 50+, both domestically and internationally. As a Director of Market Innovation in AARP’s Enterprise Strategy and Innovation group, Jeff helped to launch, and now co-manages, the Innovation@50+ initiative, which aims to spark entrepreneurial activity across public and private sectors. Anchored by the AARP social mission – to enhance the quality of life for all as we age – the program enlists the expertise of visionary thinkers, entrepreneurs, the investment community, industry, and not-for- profits to spur innovation to meet the needs and wants of people over 50.

A frequent public speaker and recognized expert on the needs and wants of the 50+, Jeff speaks regularly at industry events and conferences including Digital Health Summit, Healthbeat, Health 2.0, HXR Refactored, SilversSummit, Medcity Converge, What’s Next Boomer Business Summit. He has been quoted in publications such as Fast Company, Venturebeat.com, NPR.org, USA Today, Forbes.com and AARP the Magazine.

Mr. Makowka earned a Bachelors of Arts in Philosophy and English Literature (double major) and received his Masters of Arts (Licentiate) in Philosophy (Magna Cum Laude).

James R. Mault, M.D., F.A.C.S., is the VP & Chief Medical Officer of Qualcomm Life. Dr. Mault has more than 30 years of experience in executive positions in the HIT & Med Device industries as well as clinical medicine. He’s been board-certified in both General Surgery & Cardiothoracic Surgery. Mault conducted academic medical research under numerous grant awards from the National Institutes of Health, American Cancer Society, and others. Mault holds a bachelor’s degree in Biology and a Medical Degree from the University of Michigan, and conducted his General Surgery & Cardiothoracic Surgery residency training at Duke University Medical Center.

Chris works in Aon’s Corporate Strategy group and focuses on health care delivery system transformation. She has worked on more than two dozen M&A/divestiture projects, facilitating the redesign and integration of benefit offerings, achieving vendor efficiencies of scale, implementation of new programs and benefit offerings, and administration and communication integration. Chris also helped establish Aon’s Delivery System Transformation (DST) team. She leverages enterprise-wide solutions to advise health systems and employer groups that are interested in the evaluation and implementation of, and participation in new care delivery models such as Accountable Care Organizations and Patient-Centered Medical Homes.

Rebecca Palm is the Co-Founder and Chief Strategy Officer of Copatient. Prior to Copatient, Rebecca worked at athenahealth in Product Management and Mergers and Acquisitions. Her time with athenahealth made Rebecca acutely aware of some of the greatest challenges facing the industry, and those it is intended to serve. Rebecca founded Copatient in an effort to alleviate one of the most serious systemic flaws in our healthcare system – medical bill errors and complexity. Copatient helps consumers and businesses take control of healthcare expenses, with the most comprehensive, hassle-free healthcare expense management services available. Copatient works to resolve billing errors and ensures that provider payments are appropriate for the services provided by using crowd-sourced data and a proprietary technology platform to analyze and negotiate bills.

Arundhati Parmar is VP and Editorial Director at MedCity News. Previously she was senior editor at UBM’s Medical Device + Diagnostic Industry and has been a business journalist for more than a decade. Arundhati has three degrees from three continents – a Bachelor of Arts in English from Jadavpur University, Kolkata, India; a Masters in English Literature from the University of Sydney, Australia and a Masters in Journalism from Northwestern University in Chicago. She has sworn never to enter a classroom again.

Kirk Pion is Vice President of Design & Development for the UnitedHealthcare Innovation Centers of Excellence, an innovation lab that creates new health programs for the company’s major business segments. He’s responsible for the Centers’ innovation pipeline and pilot portfolio, with efforts focused on improving health care affordability, consumer engagement, nutrition, wearable health and caregiving. He has more than 25 years of experience in innovation, health care and business consulting. Prior to UnitedHealthcare, he spent 15 years with a regional health plan in a variety of product development and marketing roles. He helped significantly grow that organization’s membership in consumer-directed health plans, overseeing the development of value-based plan designs and integrated health and disability programs. He holds a bachelor’s degree in political science from Macalester College and a Master of Health Administration from the University of Michigan.

Naveen Rao is a healthcare writer, analyst, and advisor working at the intersection of tech, policy and business. He’s worked with leading healthcare systems on quality improvement; led the patient-centered digital health strategy at a global cancer advocacy foundation, and authored numerous market research reports on patient engagement technology. He recently founded Patchwise Labs to work directly with health tech startups on a range of strategic and creative projects. He encourages you to say hi on twitter @naveen101.

Marcie Reilly joined Cleveland Clinic in 2010 and leads a national team as a Director within the Global Healthcare Innovations Alliance. The Alliance is a collaborative network of healthcare systems and corporate partners committed to commercializing medical technologies for the benefit of patients. Marcie focuses on leveraging existing capabilities across the Alliance and identifies new strategic partners to add value to the network. Prior to joining CCI, Marcie drove the development of several products at Kensey Nash Corporation in the fields of interventional cardiology and soft tissue repair. Marcie received her BS and MS in Materials Engineering from Drexel University.

Roy Rosin is Chief Innovation Officer at Penn Medicine, working to rapidly design, test and implement high impact health care delivery practices. His team reimagines interventions to achieve improved patient experience and outcomes.

Previously, Roy served as the first VP of Innovation for Intuit, a leading software company best known for Quicken and TurboTax. In this role, he led changes in how Intuit managed new business creation, allowing teams to experiment quickly at low cost. After five years, the company delivered shareholder returns 33x the S&P 500.

Prior to leading innovation, Roy’s Quicken team achieved record profitability and product leadership while growing to 14 million consumers. Roy’s 18 years with Intuit spanned the early years in software to their emergence as a leading SaaS provider.

Ms. Ruigh is the SVP of Product Management for American Well, and is responsible for the company’s product strategy and communication. She oversees the growth of American Well’s product suite, integration tools, and applications across industry sectors. Ms. Ruigh works with each of American Well’s partners to understand virtual healthcare dynamics and drive industry innovation.

Prior to joining American Well, Ms. Ruigh managed Enterprise Technology engagements within Deloitte Consulting’s Healthcare practice. Ms. Ruigh holds a degree in Computer Science from Boston College in Chestnut Hill, MA.

Nationally known for her work in the field of accountable care and patient engagement, Dr. Katherine Schneider’s mission is to deliver better health, better care, and sustainable cost in the communities that we work in, live in, and serve. As President and CEO, Dr. Schneider provides leadership, strategic direction and ongoing administration and management for all aspects of the Delaware Valley Accountable Care Organization, the Philadelphia region’s largest including more than 670 primary care physicians and five health systems. She is a board-certified Family Physician with an additional degree in Epidemiology. Dr. Schneider is currently a board member of the National Association of ACOs (NAACOS) and chairs their Policy and Planning Committee.

Chris Seper is regional general manager for digital at E.W. Scripps, responsible for contributing to and implementing digital media strategy for Scripps’ television markets. Seper founded MedCity News and forged its unique approach to support the converged ecosystem of healthcare innovation, later serving as vice president of healthcare for Breaking Media. He’s been a speaker at conferences held by the likes of Cleveland Clinic and AARP, and continues to serve with Breaking Media in an advisory and governance capacity.

Richard Snyder, M.D. is the senior vice president and chief medical officer at Independence Blue Cross (IBC). In this role, he is the company’s chief clinical spokesperson, and he has overall corporate responsibility for medical, quality and pharmacy management, and all clinical policies and programs.

Dr. Snyder currently leads IBC’s efforts to improve the quality of patient care by transforming all primary care delivery to the patient-centered medical home model, supported by specialists and hospitals working in accountable care organizations.

Dr. Snyder is active in a variety of state and professional advisory committees. He chairs the National Council of Physician and Pharmacy Executives at the Blue Cross Blue Shield Association, and serves on the boards of the Health Care Improvement Foundation; HealthShare Exchange of Southeastern Pennsylvania, a regional health information organization (HIO); and Pennsylvania eHealth Partnership Authority, which is responsible for providing statewide and national exchange among HIOs. He also serves as chair of the board of directors for the American Heart Association Association of Southeastern, PA, Great River Affiliate.

He is a member of the American Medical Association, the Pennsylvania Medical Society, the American Academy of Family Physicians, and the Pennsylvania Academy of Family Physicians.

Dr. Snyder is a graduate of Franklin & Marshall College and the Medical College of Pennsylvania. He is board certified by the American Board of Family Medicine.

Nick is the Senior Director of Product Management at Arcadia Healthcare Solutions, designing the next wave of advanced Healthcare Analytics applications. Nick has worked with large health systems and payers to design and manage development of innovative clinical integration and business intelligence solutions to drive improved health outcomes and reduced system costs.  He’s now focusing that experience and energy into the rapid expansion of Arcadia’s own analytics and population health product suite.  Arcadia Analytics mines detailed data from EHRs, Claims and other datasets to drive improved contract performance, patient health, and cost reduction. Nick is passionate about good design and data visualization. The modern, intuitive visualizations and user-driven design found throughout Arcadia’s software have been critical to the fast growth of the business. Nick is a graduate of Tufts University in Medford, Massachusetts with a dual degree in Economics and Foreign Policy.

David is currently the Market President for Accountable Care Solutions from
Aetna, responsible for the design, development and execution of ACO
collaborations, partnering with industry leading integrated delivery systems and
clinically integrated networks.
He is responsible for the development of strategy and execution to launch
innovative, value-based, risk sharing ventures producing private label and
cobranded ACO products for fully and self insured commercial individual,
exchange, small group, public and labor, Large group and national accounts,
Medicare Advantage products in key markets including but not limited to New
Jersey, New York, and New England.

Neil Versel joined MedCity News in April 2015, writing about healthcare technology. He covers how hospitals, health insurance companies and other parts of the medical industry leverage cutting-edge technologies: from health IT to telemedicine to healthcare social media.
Versel has been covering healthcare IT since 2000, across a wide range of publications in the U.S., Canada and Europe, including U.S. News & World Report, Forbes.com and multiple healthcare industry publications. He has been blogging on health information technology since 2004.
A graduate of Washington University in St. Louis, Versel lives in Chicago.

David Vivero is CEO at Amino, a company working to create the clearest picture of American health care and help people make confident health care decisions. David co-founded Amino in 2013 and currently guides the vision and direction of the company and its personalized, data-driven products. Previously David was VP of Rentals at Zillow, responsible for the world’s largest online rental marketplace, following the acquisition of RentJuice, a company he cofounded in 2008. David is also a General Partner at Red Swan Ventures. A Forbes “30 under 30” entrepreneur, David has a BA and MBA from Harvard University.

Matthew Warrens has nearly twenty years of experience in the health care industry, with his primary expertise being health system operations and administration. Currently, he is the Vice President of Innovation for the Ministry. Health care innovation is a key initiative for OSF HealthCare. Matthew is involved daily in vetting health care solutions and determining what processes and technologies would provide benefit to the system. He works closely with clinicians, technology experts, and various professionals with specialized expertise to test disruptive technologies and understand the best way to accelerate adoption of those chosen for implementation.

Scott Whitaker is president and CEO of AdvaMed, the world’s largest medical technology association. AdvaMed members make the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments, to help people live longer, healthier lives. AdvaMed members range from the largest to the smallest medical technology innovators and companies. As CEO of AdvaMed, Whitaker is the voice of the medical technology industry. He is widely recognized as a top health care advocate and policy expert with experience across multiple health policy sectors, having worked successfully with diverse stakeholder groups – including hospital, patient and physician groups, regulators, public and private payers, and global trade organizations – to advance medical technology innovation and timely patient access to next- generation treatments and cures.

Prior to AdvaMed, Whitaker was chief operating officer of the Biotechnology Innovation Organization (BIO), the world’s largest trade association representing biotechnology companies, and president of the BIO International Convention, the world’s largest biotech conference. Whitaker also previously served as chief of staff of the U.S. Department of Health & Human Services (HHS) where he managed the day-to- day operations of the department; led the department’s activities on all major policy and management issues and initiatives; and served as the top liaison to the White House on policy, management and political matters. He also served as assistant secretary for legislation at HHS from 2001 to 2003. Whitaker began his Washington career on Capitol Hill, where he worked for U.S. Senator Don Nickles (R-Okla.). Whitaker holds a master’s degree in government from Johns Hopkins University and a degree in political science from Palm Beach Atlantic University.

Shelley has over ten years of experience in technology as a software engineer, research scientist, business executive, and venture capitalist. Shelley was formerly EVP of Business Development at Ecoplast Technologies, where she oversaw business development & sales efforts in North America. Previously, Shelley was a Principal at DFJ, where she was actively involved in a number of investments including Ecoplast Technologies, FeedBurner (acquired by Google for $100M), Flurry (acquired by Yahoo for $240M), PPLive (acquired by Suning for $420M), TicketsNow (acquired by Ticketmaster for $265M), Xfire (acquired by Viacom for $102M), YeePay. Shelley is a techie at heart and holds a BS in Computer Science and Computer Engineering from the University of Missouri, and a PhD in Computer Science from the University of California, Berkeley.